PulmonologyNews.net

Pulmonology Xagena

Search results for "Lung cancer"

A study, published in Thorax, found a relationship between reduced forced expiratory volume in one second and the risk of lung cancer. Researchers analysed studies that examined the relationship be ...


Dietary Acrylamide was not associated with an increased risk of lung cancer, according to data from a large prospective case-cohort study. Acrylamide is formed in some starchy foods, such as pota ...


When combined with standard chemotherapy, Vandetanib ( Zactima ) improves progression-free survival for patients with advanced non-small cell lung cancer. The findings, presented at the American ...


Prolonged exposure to particulate air pollution increases the risk of lung cancer ( particularly adenocarcinoma ) even at levels below the European Union limit values, according to one of the largest ...


The results from its PRONOUNCE trial of Alimta ( Pemetrexed for injection ) for treatment of nonsquamous non-small cell lung cancer ( NSCLC ) have been presented at the American Society of Clinical On ...


It appears that people who take higher than recommended doses of carotenoid supplements hoping to keep from getting sick, may actually be doing themselves harm. The long-term use of Beta-carotene, Ret ...


Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and a research has shown that this risk increases with the ...


Lung cancer patients with comorbid conditions such as chronic obstructive pulmonary disease ( COPD ), diabetes mellitus, or congestive heart failure had a higher risk of death than lung cancer patient ...


Alectinib ( Alecensa ) is a second-generation, orally active, potent and highly selective inhibitor of anaplastic lymphoma kinase ( ALK ). Alectinib is approved for the treatment of ALK fusion-gen ...


Data were reported from across AstraZeneca’s industry-leading lung cancer portfolio at the World Conference on Lung Cancer ( WCLC ) 2015, in Denver, Colorado ( U.S. ). 25 abstracts ( including 9 oral ...


Epidermal growth factor receptor-tyrosine kinase inhibitors ( EGFR-TKIs ) are a critical member of systemic therapy for advanced non-small-cell lung cancer ( NSCLC ). Erlotinib ( Tarceva ) is the ...


MicroRNAs ( miRNAs ) are endogenous small ( 19-24 nt long ) noncoding RNAs that regulate gene expression in a sequence specific manner. An increasing association between miRNA and cancer has been re ...


Haemoptysis is a serious symptom with various aetiologies. The aim of a study was to define the aetiologies, outcomes and associations with lung cancer in the entire population of a high-income countr ...


Idiopathic pulmonary fibrosis ( IPF ) is a progressive diffuse lung disease associated with an increased risk of lung cancer. Patients with idiopathic pulmonary fibrosis sometimes develop a life-threa ...


The aim of a study was to explore the efficacy and safety of Crizotinib ( Xalkori ) versus Platinum-based double agent chemotherapy as the first-line treatment in patients with advanced anaplastic lym ...